Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VREX · against 596 other Healthcare companies listed in US-listed
Ranked #366 of 597 · scores higher than 39% of peers · safety percentile 30
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)54 peers with a safety percentile of 30–39, including VREX · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VREX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.74× | 0.23× | 27% | 33% | |
| BetaLower is better · 556 reported | 0.96 | 0.95 | 49% | 33% | |
| Current ratioHigher is better · 600 reported | 3.38× | 3.91× | 45% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 362 | 354M USD | 31 | 13 | |
| 363 | 38.4B USD | 31 | 50 | |
| 364 | 119.1B USD | 30 | 57 | |
| 365 | 45.2B USD | 30 | 46 | |
| 366 | 787M USD | 30 | 57 | |
| 367 | 2.3B USD | 30 | 52 | |
| 368 | 189.3B USD | 30 | 45 | |
| 369 | 1.7B USD | 30 | 35 | |
| 370 | 433M USD | 30 | 81 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score